Ethical issues of clinical trials in children: A European perspective

Archives of Disease in Childhood

Volumn 94, Issue 6, 2009, Pages 474-477

  Sammons, Helen ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

CHILD HEALTH CARE; CLINICAL RESEARCH; DRUG SAFETY; EUROPEAN UNION; HUMAN; MEDICAL ETHICS; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

ADOLESCENT; AGE FACTORS; BIOMEDICAL RESEARCH; CHILD; CLINICAL TRIALS AS TOPIC; EUROPE; FEMALE; HUMANS; INFORMED CONSENT; INTERNATIONALITY; MALE; PEDIATRICS; PHARMACEUTICAL PREPARATIONS; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT;

EID: 66749099694     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2008.149898     Document Type: Review

References (31)

1. Choonara I. Unlicensed and off-label drug use in children: implications for safety. Expert Opin Drug Saf 2004;3:81-83 (Pubitemid 38765189)
2. European Parliament and the Council of the European Union. Regulation (EC) No 1902/2006 of the European Parliament and the Council on medicinal products for paediatric use. Published in the Official Journal of the European Union on 27/12/2006 (L 378/20).
3. Benjamin DKJ, Smith PB, Murphy D, et al. Peer-reviewed publication of clinical trials completed for pediatric exclusivity. JAMA 2006;296:1266-1273 (Pubitemid 44394898)
4. Sammons HM. Ethical considerations for clinical trials on medicinal products conducted in the paediatric population. Recommendations of the ad hoc group for the development of implementing guidelines for Directive 2001/20/EC relating to good clinical practice in the conduct of clinical trials on medicinal products for human use. http://ec.europa.eu/enterprise/ pharmaceuticals/eudralex/vol-10/ethical-considerations.pdf (accessed 27 Aug 2008).
5. De Wildt SA, Johnson TN, Choonara I. The effect of age on drug metabolism. Paediatr Perinat Drug Ther 2003;5:101-106 (Pubitemid 36781103)
6. Turner SA, Longworth A, Nunn AJ, et al. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ 1998;316:343-345 (Pubitemid 28121257)
7. Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates [see comment]. Arch Dis Child Fetal Neonatal Ed 1999;80:F142-4. (Pubitemid 29122218)
8. Tafuri G, Trotta F, Leufkens HGM, et al. Off-label use of medicines in children: can available evidence avoid useless paediatric trials? Eur J Clin Pharmacol. http://dx.doi.org/10.1007/s00228-008-0560-0 (accessed 25 Feb 2009).
9. Rothmier JD, Lasley MV. Factors influencing parental consent in pediatric clinical research. Pediatrics 2003;111:1037-1041 (Pubitemid 36542618)
10. Sammons HM, Atkinson M, Choonara I, et al. What motivates British parents to consent for research? A Questionnaire Study. BMC Pediatr 2007;7:12. (Pubitemid 46470526)
11. Ondrusek N, Aramovitch R, Pencharz P, et al. Empirical examination of the ability of children to consent to clinical research. J Med Ethics 1998;24:158-65. 12. John T, Hope T, Savulescu J, et al. Children's consent and paediatric research: is it appropriate for healthy children to be the decision makers in clinical research? Arch Dis Child 2008;93:379-383 (Pubitemid 28274480)
12. Charlebois JE, Lum BL, Cooney GF, et al. Comparison and validation of limited sampling equations for cyclosporine area-under-the-curve monitoring calculations in pediatric renal transplant recipients. Ther Drug Monit 1997;19:277-280 (Pubitemid 28053481)
13. Loebstein RMD, Koren GMD. The Ethics of multiple blood sampling in children for research. Ther Drug Monit 1997;19:251. (Pubitemid 28053476)
14. Flynn JT, Nahata MC, Mahan JD Jnr, et al. Population pharmacokinetics of amlodipine in hypertensive children and adolescents. J Clin Pharmacol 2006;46:905-916 (Pubitemid 44050827)
15. Desfrere L, Zohar S, Morville P, et al. Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method. J Clin Pharm Ther 2005;20:121-132 (Pubitemid 41583606)
16. Bourgoin H, Paintaud G, Buchler M, et al. Bayesian estimation of cyclosporine exposure for routine therapeutic drug monitoring in kidney transplant patients. Br J Clin Pharmacol 2005;59:18-27. (Pubitemid 40040092)
17. Krumbiegel P, Herbarth O, Kiess W, et al. Diagnosis of Helicobacter pylori infection in children: is the 15N urine test more reliable than the 13C breath test? Scand J Gastroenterol 2000;35:353-358
18. Parker A, Pritchard CP, Preston T, et al. Induction of CYP1A2 activity by carbamazepine in children using the caffeine breath test. Br J Clin Pharmacol 1998;45:176-178 (Pubitemid 28045689)
19. Naserke HE, Dozio N, Ziegler AG, et al. Comparison of a novel micro-assay for insulin autoantibodies with the conventional radiobinding assay. Diabetologia 1998;41:681-683 (Pubitemid 28261403)
20. Franck LS, Greenburg CS, Stevens B, et al. Pain assessment in infants and children. Pediatr Clin North Am 2000;47:487-512. (Pubitemid 30266181)
21. Miller FG, Shorr AF. Unnecessary use of placebo controls. Arch Intern Med 2008;162:673-677
22. Shapiro G, Mendelson L, Kraemer MJ, et al. Efficacy and safety of Budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma. J Allergy Clin Immunol 1998;102:789-796 (Pubitemid 28543529)
23. Shah S, Whittle A, Wilfond B, et al. How do institutional review boards apply the federal risk and benefit standards for pediatric research? JAMA 2004;291:476-482
24. Wendler D, Jenkins T. Children's and their parents' views on facing research risks for the benefit of others. Arch Pediatr Adolesc Med 2008;162:9-14.
25. Sammons HM, Gray C, Hudson H, et al. Safety in paediatric clinical trials - a 7 year review. Acta Paediatr 2008;97:474-477
26. Health Canada Therapeutic products Directorate. Adoption of ICH Guidance: Clinical Investigation of Medicinal Products in the Pediatric Population E11. http://www.hc-sc.gc.ca/dhp-mps/prodpharma/applic-demande/guide-ld/ich/efficac/ e11-eng.php (accessed 27 Aug 2008).
27. American Academy of Pediatrics. Committee on Drugs. Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Pediatrics 1995;95:286-294
28. Matsui D, Lim R, Tschen T, et al. Assessment of the palatability of beta-lactamase-resistant antibiotics in children. Arch Pediatr Adolesc Med 1997;151:599-602. (Pubitemid 27262286)
29. Sammons HM, Malhotra J, Choonara I, et al. British and Canadian views on the ethics of paediatric clinical trials. Eur J Clin 2007;63:431-436 (Pubitemid 46569925)
30. Stenson BJ, Becher C, McIntosh N, et al. Neonatal research: the parental perspective. Arch Dis Child Fetal Neonatal Ed 2004;89:F321. (Pubitemid 38869672)
31. Madsen LP. Impact of blood sampling in very preterm infants. Scand J Clin Lab Invest 2000;60:125. (Pubitemid 30202967)